Jill Feldman discusses the background of the phase 2 COCOON trial in advanced non–small cell lung cancer with EGFR mutations.
Jill Feldman
Jill Feldman is the co-founder of EGFR Registers, a patient advocacy group in Deerfield, Illinois.
Articles by Jill Feldman